Spire Healthcare Group plc (SPI.L)
- Previous Close
247.00 - Open
245.50 - Bid 247.00 x --
- Ask 247.50 x --
- Day's Range
245.50 - 249.00 - 52 Week Range
204.00 - 321.71 - Volume
392,663 - Avg. Volume
554,921 - Market Cap (intraday)
995.416M - Beta (5Y Monthly) 0.99
- PE Ratio (TTM)
35.21 - EPS (TTM)
0.07 - Earnings Date Feb 29, 2024
- Forward Dividend & Yield 0.03 (1.05%)
- Ex-Dividend Date May 23, 2024
- 1y Target Est
297.86
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers in-patient, daycase, and out-patient care services through hospitals and clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
www.spirehealthcare.com12,787
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SPI.L
Performance Overview: SPI.L
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SPI.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SPI.L
Valuation Measures
Market Cap
995.42M
Enterprise Value
2.20B
Trailing P/E
37.35
Forward P/E
24.04
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.75
Price/Book (mrq)
1.35
Enterprise Value/Revenue
1.62
Enterprise Value/EBITDA
9.59
Financial Highlights
Profitability and Income Statement
Profit Margin
2.01%
Return on Assets (ttm)
3.56%
Return on Equity (ttm)
3.81%
Revenue (ttm)
1.36B
Net Income Avi to Common (ttm)
27.3M
Diluted EPS (ttm)
0.07
Balance Sheet and Cash Flow
Total Cash (mrq)
53.6M
Total Debt/Equity (mrq)
170.37%
Levered Free Cash Flow (ttm)
50.16M
Research Analysis: SPI.L
Company Insights: SPI.L
SPI.L does not have Company Insights